BioCryst Pharmaceuticals, Inc. Share Price
NASDAQ: BCRX | Small CapBioCryst Pharmaceuticals, Inc. Stock Performance
BioCryst Pharmaceuticals, Inc. Share Price Today
As of 31 October 2026, BioCryst Pharmaceuticals, Inc.'s share price is $8.47. The stock opened at $8.54, compared to its previous close of $8.53. During today's trading session, BioCryst Pharmaceuticals, Inc.'s share price traded between $8.38 and $8.61, with an average price of $8.49. Over the past 52 weeks, the stock has recorded a high of $11.21 and a low of $6.24. In terms of performance, BioCryst Pharmaceuticals, Inc.'s share price has declined by 7.53% over the last six months and is up 15.71% on a year-on-year basis.
BioCryst Pharmaceuticals, Inc. Share Price Chart
BioCryst Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
BioCryst Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
BioCryst Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $8.28 | $8.46 | +1.74% |
Sep 2026 | $9.70 | $8.31 | -15.75% |
Aug 2026 | $8.96 | $9.87 | +10.03% |
Jul 2026 | $10.05 | $8.97 | -10.30% |
Jun 2026 | $8.81 | $10.00 | +12.04% |
May 2026 | $9.15 | $8.93 | -2.57% |
Apr 2026 | $9.54 | $9.16 | -3.78% |
Mar 2026 | $8.62 | $9.52 | +8.80% |
Feb 2026 | $6.53 | $8.75 | +33.08% |
Jan 2026 | $7.83 | $6.58 | -15.81% |
Dec 2025 | $7.06 | $7.81 | +8.77% |
Nov 2025 | $7.07 | $7.18 | -1.91% |